ACTRN12616000667415
Completed
未知
Evaluation of the efficacy and mechanism of action of intense pulsed light for the treatment of meibomian gland dysfunction
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Meibomian gland dysfunction
- Sponsor
- The University of Auckland
- Enrollment
- 87
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Participants with symptomatic dry eye caused by meibomian gland dysfunction.
Exclusion Criteria
- •Contraindications to light therapy e.g. clinical skin treatments within last two months, implants beneath the lower eyelid area, tattoos, semi\-permanent make\-up, or pigmented lesions in the treatment area will also be excluded from the study. Contact lens wearers must refrain from wearing contacts within one week of commencing the study, and during the study. Individuals taking prescribed photosensitising medications such as doxycycline within 3 months of study commencement.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effect of female sex hormones on traumatic brain injuryTraumatic brain injury.Diffuse brain injuryIRCT2014042017356N1Kerman Neuroscience Research Center90
Completed
Not Applicable
Relative efficacy and mechanisms of a couple-based intervention for Premenstrual SyndromePremenstrual syndromeRelationship satisfactionMental Health - Other mental health disordersReproductive Health and Childbirth - Menstruation and menopauseACTRN12616000932460Professor Jane Ussher90
Active, not recruiting
Not Applicable
A Mechanism of Action study to evaluate the effects of IL-6receptor blockade with tocilizumab (TCZ) on lipids, arterialstiffness, and markers of atherogenic risk in patients withmoderate to severe active rheumatoid arthritis (RA).EUCTR2007-001114-17-GBF. Hoffmann-La Roche Limited120
Completed
Not Applicable
Evaluation of the effectiveness of an educational program for people with addiction's safer public speakingAddictive disordersJPRN-UMIN000038030Graduate School of Health Sciences, Kobe University90
Active, not recruiting
Phase 1
Assessment of the eFficacy, the onset-of-Action and the Safety of Tot'héma ® in adults with moderate iron deficiency anaemiaModerate iron deficiency anaemiaMedDRA version: 20.0Level: LLTClassification code 10002062Term: Anaemia iron deficiencySystem Organ Class: 100000004851Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]EUCTR2019-003202-27-FRaboratoire Innotech Internationnal270